Biopharmaceutical Analysis & Statistics in North America Countries, December 2014 (p7)

181-210 of about 700 reports

Purchase Reports From Reputable Market Research Publishers

Western Equine Encephalitis - Pipeline Review, H2 2014

Western Equine Encephalitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Western Equine Encephalitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Western Equine Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Western Equine Encephalitis’s ...

  • Industries : Biopharmaceutical, Drug and Medication, Pathology
  • Countries : World, Venezuela, United States
Pneumocystis Infection - Pipeline Review, H2 2014

Pneumocystis Infection - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Pneumocystis Infection - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pneumocystis Infection - Pipeline Review, H2 2014’, provides an overview of the Pneumocystis Infection’s therapeutic ...

  • Industries : Biopharmaceutical, Pathology, Drug and Medication, Pharmaceutical
  • Countries : United States, World
Thrombosis - Pipeline Review, H2 2014

Thrombosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Thrombosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H2 2014’, provides an overview of the Thrombosis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Integral Molecular, Inc. - Product Pipeline Review - 2014

Integral Molecular, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Integral Molecular, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Integral Molecular, Inc. - Product Pipeline Review - 2014’, provides an overview of the Integral Molecular, ...

  • Industries : Biopharmaceutical, Research and Development
  • Countries : World, United States
Clearside BioMedical, Inc. - Product Pipeline Review - 2014

Clearside BioMedical, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Clearside BioMedical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Clearside BioMedical, Inc. - Product Pipeline Review - 2014’, provides an overview of the Clearside BioMedical, ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Ureter Cancer - Pipeline Review, H2 2014

Ureter Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Ureter Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H2 2014’, provides an overview of the Ureter Cancer’s therapeutic pipeline. This report ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Acute Lymphoblastic ...

  • Industries : Pathology
  • Countries : United States, World
Gastroenteritis - Pipeline Review, H2 2014

Gastroenteritis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Gastroenteritis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Gastroenteritis - Pipeline Review, H2 2014’, provides an overview of the Gastroenteritis’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States
Vasculitis - Pipeline Review, H2 2014

Vasculitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Vasculitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Vasculitis - Pipeline Review, H2 2014’, provides an overview of the Vasculitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Pulmonary Fibrosis - Pipeline Review, H2 2014

Pulmonary Fibrosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : United States
Cat Allergy - Pipeline Review, H2 2014

Cat Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Cat Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cat Allergy - Pipeline Review, H2 2014’, provides an overview of the Cat Allergy’s therapeutic pipeline. This report provides ...

  • Industries : Drug and Medication, Biopharmaceutical, Pharmaceutical
  • Countries : World, Canada
Schistosomiasis - Pipeline Review, H2 2014

Schistosomiasis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Schistosomiasis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Schistosomiasis - Pipeline Review, H2 2014’, provides an overview of the Schistosomiasis’s therapeutic pipeline. This ...

  • Industries : Pathology, Pharmaceutical
  • Countries : World, United States
Merck & Co., Inc. - Strategy and SWOT Report

Merck & Co., Inc. - Strategy and SWOT Report

  • $ 175
  • Company report
  • December 2014
  • by MarketLine

Merck & Co., Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings ...

  • Industries : Drug and Medication, Pharmaceutical
  • Countries : United States
Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

  • $ 2 838
  • Industry report
  • December 2014
  • by La Merie Publishing

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants A Pipeline Landscape Analysis and Comparative ...

  • Industries : Pathology, Biopharmaceutical
  • Countries : United States
Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014’, provides an overview of the Anaplastic ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Shigella Infections (Shigellosis) - Pipeline Review, H2 2014

Shigella Infections (Shigellosis) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Shigella Infections (Shigellosis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Shigella Infections (Shigellosis) - Pipeline Review, H2 2014’, provides an overview of the Shigella ...

  • Industries : Biopharmaceutical, Drug and Medication, Pathology, Pharmaceutical
  • Countries : United States
Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014’, provides an overview ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
X-BODY BioSciences, Inc. - Product Pipeline Review - 2014

X-BODY BioSciences, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

X-BODY BioSciences, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘X-BODY BioSciences, Inc. - Product Pipeline Review - 2014’, provides an overview of the X-BODY BioSciences, ...

  • Industries : Biopharmaceutical, In Vitro Diagnostic, In Vitro Diagnostic, Research and Development, Pathology, Diagnostics, Diagnostics
  • Countries : United States, World
Syntiron LLC - Product Pipeline Review - 2014

Syntiron LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Syntiron LLC - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Syntiron LLC - Product Pipeline Review - 2014’, provides an overview of the Syntiron LLC’s pharmaceutical research ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : United States, World
Spring Bank Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Spring Bank Pharmaceuticals, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Spring Bank Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Spring Bank Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the ...

  • Industries : Pharmaceutical
  • Countries : United States
Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc.

  • $ 99
  • Company report
  • December 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Accentia Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States, World
iCo Therapeutics Inc. - Product Pipeline Review - 2014

iCo Therapeutics Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

iCo Therapeutics Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘iCo Therapeutics Inc. - Product Pipeline Review - 2014’, provides an overview of the iCo Therapeutics Inc.’s ...

  • Industries : Pathology
  • Countries : World, Canada
Immune Design Corp. - Product Pipeline Review - 2014

Immune Design Corp. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Immune Design Corp. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Research and Development
  • Countries : United States
Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Shin Nippon Biomedical Laboratories, Ltd. - Product Pipeline Review - 2014’, provides ...

  • Industries : Biopharmaceutical
  • Countries : United States
Myasthenia Gravis - Pipeline Review, H2 2014

Myasthenia Gravis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Myasthenia Gravis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myasthenia Gravis - Pipeline Review, H2 2014’, provides an overview of the Myasthenia Gravis’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Tauopathies - Pipeline Review, H2 2014

Tauopathies - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Tauopathies - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Tauopathies - Pipeline Review, H2 2014’, provides an overview of the Tauopathies’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical, Biopharmaceutical
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H2 ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Sarcoidosis - Pipeline Review, H2 2014

Sarcoidosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Sarcoidosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Sarcoidosis - Pipeline Review, H2 2014’, provides an overview of the Sarcoidosis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical, Drug and Medication
  • Countries : United States, World
Plague - Pipeline Review, H2 2014

Plague - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Plague - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Plague - Pipeline Review, H2 2014’, provides an overview of the Plague’s therapeutic pipeline. This report provides comprehensive ...

  • Industries : Biopharmaceutical, Pathology, Drug and Medication, Pharmaceutical
  • Countries : United States
Myotonic Dystrophy - Pipeline Review, H2 2014

Myotonic Dystrophy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Myotonic Dystrophy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myotonic Dystrophy - Pipeline Review, H2 2014’, provides an overview of the Myotonic Dystrophy’s therapeutic pipeline. ...

  • Industries : Genomics, Pharmaceutical, Biotechnology
  • Countries : World, United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.